Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin.
Zheng J, Wang J, Wang Q, Zou H, Wang H, Zhang Z, Chen J, Wang Q, Wang P, Zhao Y, Lu J, Zhang X, Xiang S, Wang H, Lei J, Chen HW, Liu P, Liu Y, Han F, Wang J. Zheng J, et al. Among authors: wang h, wang j, wang p, wang q. Acta Pharm Sin B. 2020 Dec;10(12):2313-2322. doi: 10.1016/j.apsb.2020.07.001. Epub 2020 Jul 12. Acta Pharm Sin B. 2020. PMID: 33354503 Free PMC article.
The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants.
Wang H, Chang Z, Cai GD, Yang P, Chen JH, Yang SS, Guo YF, Wang MY, Zheng XH, Lei JP, Liu PQ, Zhao DP, Wang JJ. Wang H, et al. Among authors: wang my, wang jj. Acta Pharmacol Sin. 2022 Apr;43(4):1024-1032. doi: 10.1038/s41401-021-00738-w. Epub 2021 Jul 28. Acta Pharmacol Sin. 2022. PMID: 34321613 Free PMC article.
140,188 results
You have reached the last available page of results. Please see the User Guide for more information.